Showing results (41-50 of 1,748) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 9, 2021
Impact of Baseline Corticosteroids on Immunotherapy Efficacy in Patients With Advanced MelanomaAdi Kartolo, Jasna Deluce, Ryan Holstead, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Competition among peptides in melanoma vaccines for binding to MHC moleculesLee W Thompson, Courtney F Garbee, Sarah Hibbitts, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonistArthur M Krieg, Susan M Efler, Michael Wittpoth, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2005
Boosting vaccinations with peptide-pulsed CD34+ progenitor-derived dendritic cells can expand long-lived melanoma peptide-specific CD8+ T cells in patients with metastatic melanomaA Karolina Palucka, Madhav V Dhodapkar, Sophie Paczesny, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 2003
Pattern of gene expression and immune responses to Semenogelin 1 in chronic hematologic malignanciesYana Zhang, Zhiqing Wang, Haichao Liu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 2003
NK cells mediate Flt3 ligand-induced protection of dendritic cell precursors in vivo from the inhibition by prostate carcinoma in the murine bone marrow metastasis modelIrina L Tourkova, Kazuo Yamabe, Gurkamal Chatta, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 17, 2003
Prostate tumor microenvironment alters immune cells and prevents long-term survival in an orthotopic mouse model following flt3-ligand/CD40-ligand immunotherapyRichard P Ciavarra, Daniel A Holterman, Roy R Brown, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 17, 2003
High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanomaGünther F L Hofbauer, Andrea Burkhart, Georges Schüler, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2004
Augmentation of antitumor immune responses by multiple intratumoral inoculations of replication-conditional HSV and interleukin-12Yukihiko Iizuka, Ayuko Suzuki, Yutaka Kawakami, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancerYuji Sato, Masao Kondo, Shigechika Kohashi, et al.Pageof 175